Zebrafish Model in Biomedical Research: An Overview
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Zebrafish (Danio rerio) serve as a crucial vertebrate model organism due to their high fecundity (100-200 eggs/spawning), external fertilization, and optically transparent embryos and larvae, facilitating direct observation of developmental processes and disease phenotypes from fertilization through organogenesis.
- Significant genetic conservation with humans, with approximately 70% of human genes having a zebrafish ortholog, enables the modeling of numerous human diseases, including cancer, cardiovascular disorders, and neurodevelopmental conditions, through genetic manipulation techniques like morpholino knockdown and CRISPR/Cas9 gene editing.
- The rapid embryonic development (e.g., gastrula by 6 hpf, functional heart by 5 dpf) and optical clarity allow for real-time imaging of cellular and organ dynamics using advanced microscopy, and enable high-throughput screening of drug candidates and toxicants in multi-well plate formats.
- Zebrafish are extensively utilized in drug discovery for high-throughput screening (HTS) by exposing larvae to compounds in water, allowing for rapid assessment of efficacy and toxicity, and are also employed in regulatory toxicology via the OECD-approved fish embryo toxicity test (FET).
- Limitations such as genetic redundancy (due to whole-genome duplication) and potential morpholino off-target effects (e.g., p53-dependent apoptosis) necessitate careful experimental design, including the use of CRISPR-generated mutants and rescue experiments for validation.
- Translational challenges exist due to differences in immune systems, brain complexity, and drug metabolism compared to mammals, requiring confirmation of key findings in mammalian models before drawing broad conclusions about human applicability.
The zebrafish (Danio rerio) is a small freshwater teleost fish native to the rivers of South Asia, particularly India and Bangladesh. As a model organism, it occupies a unique niche between the simplicity of invertebrate systems like Drosophila and the mammalian complexity of mice. The zebrafish model refers to the use of this species in scientific research to understand vertebrate biology, human disease mechanisms, and drug responses. Since its introduction to the laboratory in the 1970s, the zebrafish has become one of the most versatile and widely used vertebrate models, bridging the gap between high-throughput in vitro screens and expensive mammalian studies. Its combination of external fertilization, optical transparency, and genetic tractability makes it an indispensable tool in modern biomedical research.
Introduction to the Zebrafish Model
What is a zebrafish model?
A zebrafish model is an experimental system that uses Danio rerio to investigate biological processes, disease mechanisms, and therapeutic interventions. The model encompasses both the adult fish and, more commonly, its embryos and larvae, which are used for a wide range of assays. Zebrafish are vertebrates, meaning they share a fundamental body plan and organ systems with humans, including a brain, heart, kidneys, liver, pancreas, and a closed circulatory system. This vertebrate status is critical because many biological processes—such as neural crest cell migration, cardiac looping, and hematopoiesis—are conserved across vertebrates but absent or fundamentally different in invertebrates.
The model operates at multiple levels. At the organismal level, researchers study whole-animal physiology, behavior, and development. At the genetic level, zebrafish can be manipulated to overexpress, knock down, or knock out specific genes. At the cellular level, transgenic lines expressing fluorescent proteins allow real-time observation of cell behavior in a living animal. The zebrafish model is therefore not a single technique but an integrated platform that combines genetics, embryology, imaging, and pharmacology.
History and emergence in research
The zebrafish was first brought into the laboratory by George Streisinger at the University of Oregon in the 1970s. Streisinger recognized that zebrafish offered a unique combination of features: they are vertebrates, they produce large numbers of externally fertilized embryos, and their embryos are transparent. His pioneering work established methods for genetic screens and clonal analysis in zebrafish. The field expanded dramatically in the 1990s with large-scale forward genetic screens conducted by Christiane Nüsslein-Volhard and Wolfgang Driever, which identified thousands of mutations affecting embryonic development. These screens, analogous to those previously performed in Drosophila (see Drosophila Good Model Organisms), revealed the genetic basis of vertebrate development.
The completion of the zebrafish genome project in 2013 provided a comprehensive reference, revealing that approximately 70% of human genes have at least one zebrafish ortholog. This genetic conservation, combined with the advent of CRISPR/Cas9 gene editing in the 2010s, transformed zebrafish from a developmental biology tool into a mainstream biomedical model. Today, zebrafish are used in cancer research, cardiovascular biology, neuroscience, toxicology, and drug discovery, with thousands of laboratories worldwide employing the model.
Key Advantages of the Zebrafish Model
High fecundity and external development
A single female zebrafish can lay 100–200 eggs per spawning, and a breeding pair can produce clutches weekly. This high fecundity enables experiments that require large sample sizes, such as genetic screens or drug libraries, which would be impractical in mice. Unlike mammals, zebrafish fertilization and embryonic development occur externally. Embryos develop in a petri dish, accessible from the moment of fertilization. This external development allows direct observation of every stage of embryogenesis, from the first cleavage divisions through organ formation.
The developmental timeline is rapid. At 28.5°C, the standard rearing temperature, embryos reach the gastrula stage by 6 hours post-fertilization (hpf), the pharyngula stage by 24 hpf, and hatch from their chorions by 48–72 hpf. By 5 days post-fertilization (dpf), larvae have a functioning heart, circulatory system, liver, pancreas, and a simple nervous system capable of coordinated swimming. This rapid development means that many experiments can be completed within days rather than weeks or months.
Optical clarity and live imaging
Zebrafish embryos and larvae are optically transparent. This transparency, combined with external development, allows direct visualization of internal structures without surgery or sectioning. Researchers can observe organ formation, cell migration, and gene expression patterns in real time using standard light microscopy. The development of transgenic lines expressing fluorescent proteins—such as green fluorescent protein (GFP) under tissue-specific promoters—has revolutionized this capability. For example, a transgenic line expressing GFP in endothelial cells allows direct observation of blood vessel formation in a living embryo.
The optical clarity extends to the larval stage, which remains largely transparent for the first two weeks of life. This window is sufficient for most developmental and many disease studies. For experiments requiring longer observation, pigment mutants such as casper (a double mutant lacking both melanophores and iridophores) remain transparent into adulthood, enabling imaging of adult organs. Advanced techniques, including confocal and two-photon microscopy, can resolve individual cells and even subcellular structures within the living embryo. Time-lapse imaging captures dynamic processes such as neural crest cell migration or heart morphogenesis with high temporal resolution.
Genetic similarity to humans
The zebrafish genome comprises approximately 1.4 billion base pairs organized into 25 chromosomes, containing roughly 26,000 protein-coding genes. Comparative genomics reveals that about 70% of human genes have a zebrafish ortholog, and this figure rises to 82% for disease-associated genes. This conservation extends to gene families, signaling pathways, and regulatory networks. Key developmental pathways—Wnt, Hedgehog, Notch, and bone morphogenetic protein (BMP) signaling—are functionally conserved between zebrafish and humans.
Importantly, zebrafish possess orthologs of many human disease genes, including tumor suppressors (tp53, rb1), oncogenes (myc, ras), and genes implicated in cardiovascular and neurological disorders. This genetic conservation means that mutations in zebrafish can phenocopy human diseases, providing valuable models for mechanistic studies and drug testing. The zebrafish also has a fully sequenced genome with well-annotated gene models, facilitating the identification of orthologs and the design of targeted genetic manipulations.
Genetic Tools and Techniques in Zebrafish
Morpholino knockdown
Morpholinos are synthetic oligonucleotide analogs that bind to complementary RNA sequences and block gene expression through steric hindrance. They are approximately 25 nucleotides long and contain morpholine rings instead of ribose or deoxyribose sugars, making them resistant to nucleases. Morpholinos are injected into one-cell-stage embryos and provide a rapid, transient knockdown of gene function that lasts for 3–5 days, covering the embryonic and early larval period.
Two types of morpholinos are commonly used. Translation-blocking morpholinos bind to the 5' untranslated region or the start codon region of mRNA, preventing ribosome assembly and protein synthesis. Splice-blocking morpholinos bind to splice donor or acceptor sites on pre-mRNA, causing exon skipping or intron retention and leading to aberrant splicing and often premature stop codons. The choice between these depends on the gene and the desired outcome. Typical injection doses range from 1–10 ng per embryo, and the effect is verified by Western blot (for translation blockers) or RT-PCR (for splice blockers).
Morpholinos were the standard reverse genetics tool in zebrafish for two decades. However, they have significant limitations, including off-target effects and the potential for non-specific phenotypes such as neural necrosis and developmental delay. These issues are discussed in detail in the Limitations section. Despite these caveats, morpholinos remain useful for rapid, inexpensive knockdown studies, particularly when combined with proper controls such as a scrambled-sequence morpholino or a p53 morpholino co-injection to suppress off-target apoptosis.
CRISPR/Cas9 gene editing
The CRISPR/Cas9 system has become the primary tool for generating stable genetic mutations in zebrafish. The system uses a guide RNA (gRNA) that is complementary to a target DNA sequence, directing the Cas9 endonuclease to introduce a double-strand break at that locus. The break is repaired by non-homologous end joining (NHEJ), which frequently introduces insertions or deletions (indels) that disrupt the reading frame and create a null allele.
In practice, a gRNA is designed against a 20-nucleotide sequence adjacent to a protospacer adjacent motif (PAM) sequence (NGG in the Streptococcus pyogenes Cas9 system). The gRNA and Cas9 protein or mRNA are co-injected into one-cell-stage embryos. Injected embryos (F0) are mosaic for the mutation, but germline transmission is achieved by raising these fish to adulthood and screening their offspring. Alternatively, injecting Cas9 protein complexed with gRNA as a ribonucleoprotein (RNP) increases cutting efficiency and reduces off-target effects.
The efficiency of CRISPR in zebrafish is typically high, with many loci showing mutation rates above 50% in injected embryos. For studying gene function in the F0 generation, a technique called "crispant" analysis can be used, where injected embryos are phenotypically analyzed directly despite mosaicism. This approach is rapid but requires careful validation because mosaic animals may show weaker phenotypes than true nulls. For stable lines, heterozygous F1 fish are increased to produce homozygous F2 mutants, which are then maintained as a stable line.
CRISPR also enables knock-in strategies, where a donor template with homology arms is co-injected to introduce specific point mutations or fluorescent tags. Although knock-in in zebrafish is less efficient than in mice, recent advances using single-stranded DNA donors and optimized homology-directed repair have made this approach feasible for many loci.
Transgenic reporter lines
Transgenic zebrafish lines express a reporter gene—typically a fluorescent protein—under the control of a specific promoter or enhancer. These lines allow visualization of specific cell types, tissues, or developmental processes in living animals. The most common method for generating transgenic lines is the Tol2 transposon system. A plasmid containing the reporter construct flanked by Tol2 transposon recognition sequences is co-injected with Tol2 transposase mRNA into one-cell-stage embryos. The transposase catalyzes random integration of the construct into the genome, and germline transmission is achieved by raising injected fish and screening offspring for fluorescence.
Thousands of transgenic lines have been generated. Examples include Tg(fli1:EGFP), which labels endothelial cells and enables imaging of the vasculature; Tg(mnx1:GFP), which labels motor neurons; and Tg(myl7:GFP), which labels cardiomyocytes. These lines are invaluable for studying cell behavior, organ development, and disease progression. The Gal4/UAS system, adapted from yeast, provides a binary expression system in zebrafish. A driver line expresses the Gal4 transcription factor under a tissue-specific promoter, and a responder line carries a UAS-linked reporter. Crossing the two lines activates reporter expression in the desired tissue, allowing spatial and temporal control of gene expression.
Zebrafish in Developmental Biology
Embryonic development and fate mapping
Zebrafish have been instrumental in elucidating the principles of vertebrate embryonic development. The early embryo undergoes rapid, synchronous cleavage divisions for the first 10 cell cycles, followed by the midblastula transition at approximately 3 hpf, when zygotic transcription begins. Gastrulation begins at 6 hpf with the formation of the dorsal organizer, the shield, which is functionally homologous to the Spemann organizer in amphibians. Fate mapping studies, in which individual blastomeres are labeled with fluorescent dyes, have established the embryonic origin of all major tissues and organs.
The zebrafish has been particularly valuable for studying axis formation. The dorsal-ventral axis is established by the maternal Wnt/β-catenin pathway, which activates the expression of dorsal organizer genes such as bozozok (dharma) and chordin. The anterior-posterior axis is patterned by gradients of Wnt and retinoic acid signaling. These studies have revealed that the molecular mechanisms of axis formation are conserved across vertebrates, including humans.
Organogenesis studies
Zebrafish embryos develop all major organ systems within 5 days, making them ideal for studying organogenesis. The heart is the first organ to form and function. It begins as a linear tube that undergoes looping to form the multi-chambered structure. Mutations affecting cardiac development, such as those in nkx2.5 or hand2, have been identified in zebrafish screens and have provided insights into congenital heart defects in humans. The zebrafish heart can regenerate after injury, a capability lost in mammals, and studies of this process have identified pathways such as the PDGF and IGF signaling cascades that could inform regenerative medicine.
The zebrafish kidney (pronephros) is a simple two-tubule structure that serves as a model for nephrogenesis. The liver and pancreas develop from the foregut endoderm, and studies in zebrafish have identified key transcription factors such as pdx1 and sox9 that control pancreatic and hepatic specification. The zebrafish is also a premier model for studying angiogenesis and vascular development. The optical clarity of the embryo allows direct observation of blood vessel sprouting, and genetic screens have identified genes such as vegf and notch that regulate this process.
Zebrafish Models of Human Diseases
Cancer models
Zebrafish develop a wide range of cancers, including leukemia, melanoma, rhabdomyosarcoma, and hepatocellular carcinoma. Both transgenic and xenograft approaches are used. Transgenic models express oncogenes under tissue-specific promoters. For example, the Tg(mitfa:HRAS) model expresses an activated HRAS oncogene in melanocytes, leading to melanoma formation. These models have been used to identify genes that cooperate with oncogenes to drive tumorigenesis and to test therapeutic agents.
Xenograft models involve transplanting human cancer cell lines or patient-derived tumor cells into zebrafish embryos or larvae. Because zebrafish larvae lack a fully functional adaptive immune system until approximately 3 weeks of age, they do not reject transplanted human cells. Tumor cells labeled with a fluorescent dye can be injected into the yolk sac or the perivitelline space of 2-day-old larvae, and tumor growth, invasion, and metastasis can be quantified by fluorescence microscopy. This approach allows rapid in vivo assessment of drug efficacy against human cancer cells. The Animal Cell Culture techniques used to maintain these cell lines are a prerequisite for xenograft studies.
Cardiovascular disease models
The zebrafish has contributed significantly to our understanding of cardiovascular development and disease. Mutations affecting heart development, cardiac conduction, and vascular integrity have been identified in forward genetic screens. For example, the sih (silent heart) mutation, which disrupts the tnnt2 gene encoding cardiac troponin T, causes the heart to fail to contract, modeling dilated cardiomyopathy. The gridlock mutation, affecting the hey2 gene, causes aortic coarctation, a congenital heart defect.
Zebrafish are also used to model cardiac arrhythmias. The reggae mutation, affecting the kcnh2 gene encoding a potassium channel, causes long QT syndrome, a condition that predisposes to ventricular arrhythmias and sudden death. Drug-induced cardiotoxicity is a major concern in pharmaceutical development, and zebrafish larvae are used to screen compounds for effects on heart rate, rhythm, and morphology. The transparency of the larvae allows automated video-based analysis of cardiac function, enabling high-throughput cardiotoxicity screening.
Neurodevelopmental and neurodegenerative models
Zebrafish are increasingly used to model neurological and psychiatric disorders. The larval zebrafish has a simple but functional nervous system, and its small size and transparency allow whole-brain imaging of neural activity using genetically encoded calcium indicators such as GCaMP. This has enabled studies of neural circuits underlying behavior, including prey capture, escape responses, and social interactions.
Genetic models of neurodevelopmental disorders include mutations in genes associated with autism spectrum disorder (ASD), such as shank3 and chd8. These mutants show altered social behavior, repetitive swimming patterns, and changes in brain morphology. Zebrafish models of neurodegenerative diseases include transgenic lines expressing human tau or α-synuclein, which develop protein aggregates and show neuronal loss. The pink1 and parkin mutant lines model Parkinson's disease, showing mitochondrial dysfunction and loss of dopaminergic neurons. These models are used to screen for neuroprotective compounds and to study disease mechanisms.
Zebrafish in Drug Discovery and Toxicology
High-throughput drug screening
The zebrafish is uniquely suited for high-throughput drug screening (HTS). Adult zebrafish are not practical for HTS, but larvae can be arrayed in 96-well or 384-well plates, with one larva per well. Compounds are added to the water, and because zebrafish larvae absorb small molecules through their skin and gills, no injection is required. This allows screening of thousands of compounds in a single experiment.
Phenotypic screens are the most common approach. A transgenic reporter line or a disease model is used, and the screen looks for compounds that modify the phenotype. For example, a screen for compounds that suppress the gridlock phenotype identified a class of compounds that promote vascular development. Similarly, screens for compounds that modulate heart rate, pigmentation, or behavior have identified drugs with potential therapeutic applications. The readout can be automated using fluorescence microscopy, image analysis software, and robotic plate handling.
The advantages of zebrafish for drug screening include the ability to assess efficacy in a whole-organism context, the small amount of compound required (typically 1–10 µM in the water), and the speed of the assay. A typical screen can be completed in 3–5 days. Hits are then validated in secondary assays, including mammalian cell culture and mouse models. The Scale Down Model in Bioprocess concept applies here in that zebrafish larvae represent a scaled-down whole-organism system that bridges in vitro and mammalian in vivo studies.
Toxicity testing and safety assessment
Zebrafish are widely used for toxicity testing, both in academic research and in regulatory toxicology. The fish embryo toxicity test (FET) is an OECD-approved guideline (Test No. 236) for assessing acute toxicity. Embryos are exposed to a range of compound concentrations from 24 hpf to 96 hpf, and lethal and sublethal endpoints are recorded, including coagulation, lack of somite formation, lack of heartbeat, and failure to hatch.
The zebrafish model offers several advantages for toxicity testing. The embryos are not considered animals under European Union regulations until they are capable of independent feeding (at approximately 5 dpf), which reduces regulatory burden. The small size allows testing in multi-well plates, and the transparency allows observation of internal organ toxicity, such as hepatotoxicity, cardiotoxicity, and neurotoxicity. Transgenic lines expressing fluorescent reporters under stress-responsive promoters (e.g., hsp70 or cyp1a) can report activation of specific toxicity pathways.
Zebrafish are also used to assess developmental toxicity. Because embryonic development is rapid and externally accessible, teratogenic effects can be observed directly. Compounds that cause morphological abnormalities, such as curved body axis, pericardial edema, or craniofacial defects, are flagged as potential developmental toxicants. This information is valuable for prioritizing compounds in pharmaceutical development and for environmental risk assessment.
Methods for Studying Zebrafish
Breeding and embryo collection
Zebrafish are maintained in recirculating aquarium systems with controlled water quality. The optimal temperature is 28.5°C, and the light cycle is typically 14 hours light and 10 hours dark. Breeding is triggered by the onset of light. A standard breeding setup uses a tank with a mesh bottom or a spawning trap, allowing eggs to fall through and be collected without being eaten by the adults. Embryos are collected within 30–60 minutes of spawning, rinsed, and maintained in embryo medium (E3 medium: 5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl₂, 0.33 mM MgSO₄, 0.1% methylene blue as an antifungal agent) at 28.5°C.
For experiments requiring synchronized developmental stages, embryos are staged according to standard criteria, such as the number of somites or hours post-fertilization at 28.5°C. Embryos can be maintained in petri dishes or multi-well plates, and the medium is changed daily. For long-term rearing, larvae are transferred to the aquarium system at approximately 5 dpf and fed paramecia or rotifers before transitioning to brine shrimp and dry food.
Microinjection and transplantation
Microinjection is a core technique in zebrafish research. It is used to deliver morpholinos, CRISPR reagents, mRNAs, DNA constructs, or proteins into one-cell-stage embryos. The injection setup includes a micromanipulator, a microinjector, and a stereomicroscope. Glass capillary needles are pulled to a fine tip and filled with the injection solution. The volume injected is calibrated by measuring the diameter of the droplet in mineral oil; a typical injection volume is 1–2 nL.
For transplantation experiments, cells are removed from a donor embryo and transplanted into a host embryo at the same developmental stage. This technique is used for cell lineage tracing, mosaic analysis, and generating chimeric animals. For example, to study cell-autonomous versus non-cell-autonomous gene function, mutant cells can be transplanted into a wild-type host and vice versa. The donor cells are labeled with a fluorescent dye or express a fluorescent protein to allow tracking.
Imaging techniques
The optical clarity of zebrafish enables a wide range of imaging approaches. Standard fluorescence microscopy is used for routine observation of transgenic reporters. Confocal microscopy provides higher resolution and optical sectioning, allowing three-dimensional reconstruction of structures. Two-photon microscopy enables deeper imaging with less photobleaching and phototoxicity, making it suitable for time-lapse imaging of developing embryos.
Light-sheet fluorescence microscopy has become a powerful tool for zebrafish imaging. The embryo is illuminated with a thin sheet of light, and the emitted fluorescence is collected perpendicular to the illumination plane. This allows rapid, high-resolution imaging of large specimens with minimal phototoxicity. Whole-embryo time-lapse imaging over several hours or days is feasible, capturing dynamic processes such as gastrulation, organogenesis, and neural activity.
For imaging neural activity, genetically encoded calcium indicators such as GCaMP are expressed in specific neuronal populations. Changes in intracellular calcium concentration, which reflect neuronal firing, cause changes in GCaMP fluorescence. This allows functional imaging of neural circuits in behaving larvae, correlating brain activity with behavior.
Behavioral assays
Zebrafish larvae and adults exhibit a range of behaviors that can be quantified. The larval locomotor response is commonly assessed in multi-well plates using automated tracking systems. The visual motor response (VMR) test measures the change in locomotor activity in response to a light-dark transition. Larvae typically show a burst of activity when the light is turned off, and this response can be quantified to assess visual function, neurological status, and the effects of drugs.
The startle response, elicited by a sudden acoustic or tactile stimulus, is a well-characterized behavior mediated by the Mauthner cells, a pair of large reticulospinal neurons. The prepulse inhibition (PPI) test measures the reduction in startle response when a weak stimulus precedes the strong one. Deficits in PPI are associated with schizophrenia and are used to assess the effects of antipsychotic drugs.
Adult zebrafish behavioral assays include the novel tank test (measuring anxiety-like behavior), the social preference test, and the conditioned place preference test (measuring reward-seeking behavior). These assays are used to study the neural basis of behavior and to model psychiatric disorders.
Limitations and Common Pitfalls in Zebrafish Research
Genetic redundancy and compensation
Zebrafish have undergone a whole-genome duplication event in their evolutionary history, followed by the loss of many duplicated genes. However, approximately 20–30% of zebrafish genes remain duplicated, and these paralogs often have overlapping functions. When one paralog is mutated, the other may compensate, resulting in a milder phenotype than expected. This genetic redundancy can confound loss-of-function studies. For example, the sonic hedgehog (shh) gene has a paralog, tiggy-winkle hedgehog (twhh), and single mutants of shh show a less severe phenotype than double mutants.
A related phenomenon is transcriptional adaptation, where the presence of a premature termination codon in a mutant gene triggers the upregulation of paralogous or related genes. This compensation is not observed with morpholino knockdown, which explains why morpholino phenotypes and mutant phenotypes sometimes differ. Researchers must be aware of this issue and, where possible, generate double mutants or use conditional approaches to reveal the full function of a gene.
Morpholino specificity issues
Morpholinos are prone to off-target effects, which can produce phenotypes unrelated to the target gene. The most common off-target effect is p53-dependent apoptosis, which causes widespread cell death and developmental abnormalities. This can be partially suppressed by co-injecting a p53 morpholino, but this does not eliminate all off-target effects. Other off-target effects include neural tube defects and general developmental delay.
The specificity of a morpholino must be validated. The gold standard is to show that the morpholino phenotype is rescued by co-injecting the target mRNA that is resistant to the morpholino (by introducing silent mutations in the binding site). Additionally, the phenotype of the morpholino should be compared with that of a CRISPR-generated mutant. If the phenotypes differ, the morpholino results should be interpreted with caution. Many published morpholino phenotypes have not been reproduced in CRISPR mutants, highlighting the importance of using multiple approaches.
Translational limitations
Despite the genetic conservation between zebrafish and humans, there are important differences that limit the translation of zebrafish findings to human disease. The zebrafish immune system differs from the mammalian system; for example, zebrafish lack lymph nodes and have a different repertoire of immunoglobulins. This limits their utility for studying adaptive immunity and certain infectious diseases.
The zebrafish brain is much simpler than the mammalian brain, lacking a cortex and other higher-order structures. While this simplicity is advantageous for studying basic neural circuits, it limits the modeling of complex psychiatric disorders. Drug metabolism in zebrafish differs from humans; the cytochrome P450 enzyme families are present but have different substrate specificities and expression patterns. A compound that is effective in zebrafish may be metabolized differently in humans, and vice versa. Finally, the small size of zebrafish limits the amount of tissue available for biochemical analyses, and some procedures, such as serial blood sampling, are not feasible.
Summary and Best Practices
Best practices for experimental design
When designing experiments with zebrafish, several best practices should be followed. First, use the appropriate genetic tool for the question. For rapid, transient knockdown, morpholinos are useful, but results should be validated with CRISPR mutants. For stable loss-of-function studies, CRISPR is the preferred approach. Second, always include proper controls: wild-type siblings for mutant studies, scrambled-sequence morpholinos for knockdown studies, and rescue experiments to confirm specificity.
Third, be aware of genetic redundancy and compensation. If a mutant shows a mild phenotype, consider whether paralogs may be compensating. Fourth, use the correct developmental stage for the assay. Zebrafish develop rapidly, and the stage at which an experiment is performed can dramatically affect the results. Fifth, maintain consistent water quality and temperature, as stress can confound behavioral and physiological assays. Sixth, for drug studies, determine the maximum tolerated concentration and use a range of doses to establish dose-response relationships.
Finally, consider the translational relevance of the findings. Confirm key results in mammalian systems, such as cell culture or mouse models, before drawing broad conclusions. The Operon Model and Molecular Clock Model are examples of how model systems can reveal fundamental principles, and the zebrafish model similarly contributes to our understanding of vertebrate biology and disease.
Frequently Asked Questions
What is a zebrafish model?
A zebrafish model is an experimental system that uses the freshwater fish Danio rerio to study biological processes, human diseases, and drug responses. It includes both embryos/larvae and adult fish, and it leverages the species' high fecundity, external development, optical transparency, and genetic tractability.
Why are zebrafish used as model organisms?
Zebrafish are used because they are vertebrates with significant genetic similarity to humans (about 70% of human genes have a zebrafish ortholog), they produce large numbers of externally developing embryos, and their transparent embryos allow direct observation of development and disease processes. They are also relatively inexpensive to maintain and are amenable to high-throughput screening.
What are the advantages of zebrafish over mice?
Zebrafish produce hundreds of embryos per week, whereas mice produce litters of 5–10. Zebrafish embryos develop externally and are transparent, allowing direct imaging, whereas mouse embryos develop in utero and require invasive procedures. Genetic manipulation in zebrafish is faster and less expensive, and drug screening can be performed in multi-well plates. However, mice are more similar to humans in terms of immune system, brain complexity, and drug metabolism, making them more appropriate for certain studies.
How are zebrafish used in drug discovery?
Zebrafish larvae are arrayed in multi-well plates and exposed to compounds added to the water. Phenotypic screens use transgenic reporter lines or disease models to identify compounds that modify a phenotype. Zebrafish are also used for toxicity testing, including the OECD-approved fish embryo toxicity test. Hits from zebrafish screens are typically validated in mammalian models.
Can zebrafish model human genetic diseases?
Yes. Because of genetic conservation, mutations in zebrafish orthologs of human disease genes often phenocopy the human condition. Zebrafish models exist for cancer, cardiovascular diseases, neurodevelopmental disorders, and neurodegenerative diseases. However, differences in physiology and genome organization mean that not all aspects of human disease are faithfully recapitulated.
What is the difference between morpholino and CRISPR in zebrafish?
Morpholinos are synthetic oligonucleotides that transiently block translation or splicing of a target gene. They are injected into embryos and provide knockdown for 3–5 days. CRISPR/Cas9 introduces permanent mutations in the genome, creating stable knockout lines. Morpholinos are faster but have off-target effects and do not always phenocopy mutants. CRISPR is more specific and generates heritable mutations but takes longer to establish lines.
What are common pitfalls in zebrafish research?
Common pitfalls include morpholino off-target effects, genetic redundancy and compensation by paralogous genes, differences between morpholino and mutant phenotypes, and translational limitations due to physiological differences from mammals. Other pitfalls include inconsistent water quality, incorrect developmental staging, and failure to include proper controls.
Key Takeaways
- The zebrafish model is a vertebrate system combining high fecundity, external development, optical transparency, and genetic tractability.
- Approximately 70% of human genes have a zebrafish ortholog, making it a relevant model for human disease.
- CRISPR/Cas9 is the preferred tool for generating stable knockouts, while morpholinos provide rapid but transient knockdown with caveats.
- Zebrafish are used to study development, cancer, cardiovascular disease, neurological disorders, and for drug and toxicity screening.
- The model has limitations, including genetic redundancy, morpholino off-target effects, and differences from mammalian physiology.
- Best practices include using multiple genetic approaches, proper controls, and validating findings in mammalian systems.
- Zebrafish bridge the gap between invertebrate models and mammalian models, offering a whole-organism platform for high-throughput studies.
Further Reading
- Zhu S, Thomas Look A. Neuroblastoma and Its Zebrafish Model. Advances in experimental medicine and biology. 2016. PubMed 27165366
- Tyrkalska SD et al. Zebrafish models of COVID-19. FEMS microbiology reviews. 2023. PubMed 36323404
- Deng Q et al. Zebrafish model of hyperuricemia. International journal of rheumatic diseases. 2024. PubMed 38685792
- Szychlinska MA, Marino Gammazza A. The Zebrafish Model in Animal and Human Health Research. International journal of molecular sciences. 2025. PubMed 40076570
- Her ZP et al. Zebrafish Model of Neuroblastoma Metastasis. Journal of visualized experiments : JoVE. 2021. PubMed 33779609
- Russo I et al. The Zebrafish model in dermatology: an update for clinicians. Discover oncology. 2022. PubMed 35713744